Nordic pulse oximetry screening - Implementation status and proposal for uniform guidelines

Acta Paediatrica, International Journal of Paediatrics

Volumn 103, Issue 11, 2014, Pages 1136-1142

  Granelli, Anne De Wahl ^a   Meberg, Alf ^b   Ojala, Tiina ^c   Steensberg, Jesper ^d   Oskarsson, Gylfi ^e   Mellander, Mats ^a  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b VESTFOLD HOSPITAL TRUST   (Norway)

^c UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^d International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^e LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Congenital heart disease; Guidelines; Newborn screening; Pulse oximetry

Indexed keywords

ARTICLE; CLINICAL EXAMINATION; CONGENITAL HEART DISEASE; DENMARK; ECHOCARDIOGRAPHY; FINLAND; HUMAN; ICELAND; NEWBORN; NORWAY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRENATAL SCREENING; PRIORITY JOURNAL; PULSE OXIMETRY; SCREENING TEST; SWEDEN; ALGORITHM; CLINICAL TRIAL; HEART DEFECTS, CONGENITAL; MULTICENTER STUDY; NEWBORN SCREENING; OXIMETRY; QUESTIONNAIRE; SCANDINAVIA; STANDARDS;

ALGORITHMS; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; OXIMETRY; PRACTICE GUIDELINES AS TOPIC; SCANDINAVIAN AND NORDIC COUNTRIES; SURVEYS AND QUESTIONNAIRES;

EID: 84929515675     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12758     Document Type: Article

References (30)

1. de-Wahl Granelli A, Wennergren M, Sandberg K, Mellander M, Bejlum C, Inganäs L, et al., Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39 821 newborns. BMJ 2009; 8: 338: a3037.
2. Meberg A, Andreassen A, Brunvand L, Markestad T, Moster D, Nietsch L, et al., Pulse oximetry screening as a complementary strategy to detect critical congenital heart defects. Acta Paediatr 2009; 98: 682-6.
3. Gardiner H, Kovacevic A, van der Heijden L, Pfeiffer P, Franklin R, Gibbs J, et al., Prenatal screening for major congenital heart disease: assessing performance by combining national cardiac audit with maternity data. Heart 2014; 100: 375-382.
4. Abu-Harb M, Hey E, Wren C,. Death in infancy from unrecognised congenital heart disease. Arch Dis Child 1994; 71: 3-7.
5. Mellander M, Sunnegårdh J,. Failure to diagnose critical heart malformations in newborns before discharge-an increasing problem? Acta Paediatr 2006; 95: 407-13.
6. O'Donnell CPF, Kamlin COF, Davis PG, Carlin JB, Morley CJ,. Clinical assessment of infant colour at delivery. Arch Dis Child Fetal Neonatal Ed 2007; 92: F465-7.
7. Wren C, Reinhardt Z, Khawaja K,. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed 2008; 93: F33-5.
8. Peterson C, Ailes E, Riehle-Colarusso T, Oster ME, Olney RS, Cassell CH, et al., Late detection of critical congenital heart disease among US infants. Estimation of the potential impact of proposed universal screening using pulse oximetry. JAMA Pediatr 2014; 168 (4): 361-370.
9. Meberg A, Brügmann-Pieper S, Due R Jr, Eskedal L, Fagerli I, Farstad T, et al., First day of life pulse oximetry screening to detect congenital heart defects. J Pediatr 2008; 152: 761-5.
10. Riede FT, Wörner C, Dähnert I, Möckel A, Kostelka M, Schneider P,. Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine -results from a prospective multicentre study. Eur J Pediatr 2010; 169: 975-81.
11. Ewer AK, Middleton LJ, Furmston AT, Bhoyar A, Daniels JP, Thangaratinam S, et al., Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet 2011; 378: 785-94.
12. Turska-Kmiec A, Borszewska-Kornacka MK, Błaz W, Kawalec W, Zuk M,. Early screening for critical congenital heart defects in asymptomatic newborns in Mazovia province: experience of the POLKARD pulse oximetry programme 2006-2008 in Poland. Kardiol Pol 2012; 70: 4: 370-6.
13. Thangaratinam S, Brown K, Zamora J, Khan KS, Ewer AK,. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet 2012; 379: 2459-64.
14. Zhao Q, Ma X, Ge X, Liu F, Yan W, Wu L, et al., Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study. Lancet 2014; [Epub ahead of print], published online April 23: doi: 10.1016/S0140-6736(14)60198-7
15. Sebelius K,. Secretary of Health and Human Services recommendation for pulse oximetry screening. Washington, DC: Department of Health and Human Services, 2011: http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/recommendations/correspondence/cyanoticheartsecre09212011.pdf
16. Kemper AR, Mahle WT, Martin GR, Cooley WC, Kumar P, Morrow WR, et al., Strategies for implementing screening for critical congenital heart disease. Pediatrics 2011; 128: e1259-67.
17. Martin RG, Beekman RH 3rd, Bradshaw Mikula E, Fasules J, Garg LF, Kemper AR, et al., Implementing recommended screening for critical congenital heart disease. Pediatrics 2013; 132: e185-92.
18. Singh A, Ewer AK,. Pulse oximetry screening for critical congenital heart defects: a UK national survey. Lancet 2013; 381: 535.
19. Ewer AK, de-Wahl Granelli A, Manzoni P, Sanchez-Luna M, Martin GR,. Pulse oximetry screening for congenital heart defects. Lancet 2013; 382: 856-7.
20. Afrapportering fra udvalg vedrörende rutineundersögelse af tilsyneladende raske börn. Dansk Paediatrisk Selskab og Dansk Selskab for obstetrik og gynekologi (Report from the committee concerning prophylactic health examinations of apparently healthy children in Denmark. Danish Paediatric Society and the Danish Society of Obstetrics and Gynecology) (In Danish) 2007.
21. Nytt liv og trygg barseletid for familien. Kortversjon av retningslinje for barseleomsorgen. Oslo: Helsedirektoratet. Nasjonale faglige retningslinjer;IS-2086 (New life and safe child birth time for the family. Summary of the Guidelines for maternity care. Oslo: Norwegian Health Directorate. National Guidelines IS-2086) (In Norwegian) June 2013.
22. Walsh W,. Evaluation of pulse oximetry screening in Middle Tennessee: cases for consideration before universal screening. J Perinatol 2011; 31: 125-9.
23. Tegnander E, Williams W, Johansen OJ, Blass H-GK, Eik-Nes S,. Prenatal detection of heart defects in a non-selected population of 30 149 fetuses-detection rates and outcome. Ultrasound Obstet Gynecol 2006; 27: 252-65.
24. Ojala T, Ritvanen A, Pitkänen O,. Prenatal screening and diagnosis of severe congenital heart defects in Finland. Duodecim 2013; 129: 2367-74.
25. Wehner B, Steensberg J, Reimers J, Andersen H,. Saturation screening in Denmark. Oral presentation Annual Danish Neonatology meeting. G1 Avernaes 2011.
26. Carvalho JS, Allan LD, Chaoui R, Copel JA, DeVore GR, Hecher K, et al., ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol 2013; 41: 348-59.
27. Singh A, Vishna Rasiah S, Ewer AK,. The impact of routine predischarge pulse oximetry screening in a regional neonatal unit. Arch Dis Child Fetal Neonatal Ed 2014; [Epub ahead of print], F1-6. doi: 10.1136/archdischild-2013-305657
28. de-Wahl Granelli A, Mellander M, Sunnegårdh J, Sandberg K, Östman-Smith I,. Screening for duct-dependent congenital heart disease with pulse oximetry: a critical evaluation of strategies to maximize sensitivity. Acta Paediatr 2005; 94: 1590-6.
29. Oster ME, Kuo KW, Mahle WT,. Quality improvement in screening for critical congenital heart disease. J Pediatr 2014; 164: 67-71.
30. Granelli AW, Östman-Smith I,. Noninvasive peripheral perfusion index as a possible tool for screening for critical left heart obstruction. Acta Paediatr 2007; 96: 1455-9.